Net profit of Genomic Valley Biotech reported to Rs 0.02 crore in the quarter ended December 2023 as against net loss of Rs 0.85 crore during the previous quarter ended December 2022. Sales declined 94.03% to Rs 0.04 crore in the quarter ended December 2023 as against Rs 0.67 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales0.040.67 -94 OPM %50.005.97 - PBDT0.020.05 -60 PBT0.020.05 -60 NP0.02-0.85 LP Powered by Capital Market - Live News

Genomic Valley Biotech has revised the meeting of the Board of Directors which was scheduled to be held on 10 February 2024. The meeting will now be held on 14 February 2024.Powered by Capital Market - Live News

Genomic Valley Biotech has revised the meeting of the Board of Directors which was scheduled to be held on 10 February 2024. The meeting will now be held on 14 February 2024.Powered by Capital Market - Live News

Genomic Valley Biotech will hold a meeting of the Board of Directors of the Company on 10 February 2024.Powered by Capital Market - Live News

Net profit of Genomic Valley Biotech declined 66.67% to Rs 0.02 crore in the quarter ended September 2023 as against Rs 0.06 crore during the previous quarter ended September 2022. Sales rose 250.00% to Rs 0.07 crore in the quarter ended September 2023 as against Rs 0.02 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales0.070.02 250 OPM %28.57-150.00 - PBDT0.02-0.02 LP PBT0.02-0.03 LP NP0.020.06 -67 Powered by Capital Market - Live News